Justine E. Koenigsberg
Investor Relations Contact en CONCERT PHARMACEUTICALS, INC. .
Cargos activos de Justine E. Koenigsberg
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CONCERT PHARMACEUTICALS, INC. | Investor Relations Contact | 01/03/2008 | - |
Public Communications Contact | 01/03/2008 | - | |
KYMERA THERAPEUTICS, INC. | Investor Relations Contact | 01/07/2023 | - |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - | - |
Director/Board Member | - | - |
Historial de carrera de Justine E. Koenigsberg
Antiguos cargos conocidos de Justine E. Koenigsberg.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Public Communications Contact | - | - |
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - | - |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Public Communications Contact | 01/09/2005 | - |
Formación de Justine E. Koenigsberg.
Northeastern University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 8 |
Operativa
Public Communications Contact | 3 |
Corporate Officer/Principal | 2 |
Investor Relations Contact | 2 |
Sectorial
Health Technology | 5 |
Commercial Services | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
KYMERA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Health Technology |
Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |